Phase 1 HER2-Positive Advanced Solid Tumors Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
HER2-Positive Advanced Solid Tumors
Chinese PLA General Hospital30 enrolled1 locationNCT05681650
Recruiting
Phase 1
Phase I Dose Finding Study in Patients with HER2-Positive Advanced Solid Tumors
HER2-Positive Advanced Solid Tumors
Conjugate Light (Australia) Pty Ltd13 enrolled1 locationACTRN12620000592943